AstraZeneca Symposium

AstraZeneca Breakfast Symposium

AstraZeneca Australia is part of the global science-led biopharmaceutical company, AstraZeneca. We are engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology; BioPharmaceuticals; Vaccine and Immune Therapies; and Rare Disease. We build our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines.

You’re invited to AstraZeneca’s breakfast symposium at Breast Cancer Trials 45th Annual Scientific Meeting. More information will be made available in the near future.

Friday 26 July, from 7:00 – 8:45 AM

You can register for this symposium when completing your conference registration. More information will be made available in the near future.

Guest Speakers

Andrew Tutt

International Guest Speaker